James Charles Zimring

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 6 CIPO patents and 2 EPO patents. Top assignees: Bloodworks, Bloodworks Nw. Active years: 2017-2026.

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 1.1

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

Years Active: 2017-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12584929 - COMPOSITION AND METHODS FOR ASSESSING SENSITIVITY AND SPECIFICITY OF ANTIBODY DETECTION REAGENTS (2026-03-24),

2. 12030956 - Antibodies that recognize red blood cell antigens (2024-07-09),

3. 11892458 - Biochemical predictors of red blood cell quality (2024-02-06),

4. 11693018 - Dicarboxylic acids and correlated compounds as a measure of red blood cell quality (2023-07-04),

5. 11248060 - Antibodies that recognize red blood cell antigens (2022-02-15),

6. 11085937 - Composition and methods for assessing sensitivity and specificity of antibody detection reagents (2021-08-10),

7. 11047868 - Biochemical markers of red blood cell storage and toxicity (2021-06-29),

8. 10830777 - Biochemical predictors of red blood cell quality (2020-11-10),

9. 10816557 - Dicarboxylic acids and correlated compounds as a measure of red blood cell quality (2020-10-27),

10. 10785967 - Mice with a modified glucose-6-phosphate dehydrogenase gene (2020-09-29),

11. 10677781 - STEAP3 as a biochemical marker of red blood cell storage and toxicity (2020-06-09),

12. 10578627 - Biochemical markers of red blood cell storage and toxicity (2020-03-03),

13. 10345316 - Biochemical markers of red blood cell storage and toxicity (2019-07-09),

14. 10330668 - Biochemical markers of platelet storage (2019-06-25),

15. 10274480 - Steap3 as a biochemical marker of red blood cell storage and toxicity (2019-04-30),

Title: **James Charles Zimring: Innovator in Blood Transfusion Science**

Introduction

James Charles Zimring is a prominent inventor based in Seattle, WA, with a remarkable portfolio of 17 patents. His work primarily focuses on innovations that enhance blood transfusion safety and efficacy, making significant contributions to the field of hematology.

Latest Patents

Among his latest patents are groundbreaking advancements such as "Antibodies that recognize red blood cell antigens." This invention encompasses compositions and methods for utilizing antibodies capable of identifying single amino acid polymorphisms within proteins. These innovations can be instrumental for blood typing and in preventing hemolytic transfusion reactions and hemolytic disease of the fetus and newborn.

Another noteworthy patent is related to "Biochemical predictors of red blood cell quality." This invention provides methods and compositions for determining the post-transfusion survival or toxicity of red blood cells, measuring the levels of various compounds in red blood cell samples to assess their suitability for transfusion.

Career Highlights

James Charles Zimring has made a significant impact in the field of blood research while working at notable organizations such as Bloodworks and Bloodworks Northwest. His career is marked by a commitment to developing safer and more effective blood transfusion practices, contributing both to scientific knowledge and clinical applications.

Collaborations

Throughout his career, Zimring has collaborated with esteemed colleagues, including Karen S De Wolski and Sherrill J Slichter. These collaborations have fostered a rich exchange of ideas and have enhanced the development of his innovative technologies.

Conclusion

James Charles Zimring’s contributions to the field of blood transfusion science through his numerous patents and collaborations exemplify the spirit of innovation in healthcare. His work not only enhances patient safety but also pushes the boundaries of what is possible in medical science.